<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PLCB-RA-0346R2</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1000002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Biocatalysis</subject><subject>Biochemistry/Molecular Evolution</subject><subject>Biochemistry/Protein Chemistry</subject><subject>Biochemistry/Protein Folding</subject><subject>Biochemistry/Theory and Simulation</subject><subject>Biophysics/Biocatalysis</subject><subject>Biophysics/Protein Chemistry and Proteomics</subject><subject>Biophysics/Protein Folding</subject><subject>Biophysics/Theory and Simulation</subject><subject>Computational Biology/Evolutionary Modeling</subject></subj-group></article-categories><title-group><article-title>How Protein Stability and New Functions Trade Off</article-title><alt-title alt-title-type="running-head">Protein Stability and New Functions</alt-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tokuriki</surname><given-names>Nobuhiko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stricher</surname><given-names>Francois</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Serrano</surname><given-names>Luis</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tawfik</surname><given-names>Dan S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>EMBL-CRG Systems Biology Partnership Unit, CRG-Centro de Regulacion Genomica, Barcelona, Spain</addr-line>       </aff><contrib-group><contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Eisenberg</surname><given-names>David</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of California Los Angeles, United States of America</aff><author-notes><corresp id="cor1">* E-mail: <email xlink:type="simple">tawfik@weizmann.ac.il</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: NT DT. Performed the experiments: NT. Analyzed the data: NT. Contributed reagents/materials/analysis tools: FS LS. Wrote the paper: NT DT.</p></fn><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>2</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>29</day><month>2</month><year>2008</year></pub-date><volume>4</volume><issue>2</issue><elocation-id>e1000002</elocation-id><history><date date-type="received"><day>18</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2008</year></date></history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2008</copyright-year><copyright-holder>Tokuriki et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Numerous studies have noted that the evolution of new enzymatic specificities is accompanied by loss of the protein's thermodynamic stability (ΔΔ<italic>G</italic>), thus suggesting a tradeoff between the acquisition of new enzymatic functions and stability. However, since most mutations are destabilizing (ΔΔ<italic>G</italic>&gt;0), one should ask how destabilizing mutations that confer new or altered enzymatic functions relative to all other mutations are. We applied ΔΔ<italic>G</italic> computations by FoldX to analyze the effects of 548 mutations that arose from the directed evolution of 22 different enzymes. The stability effects, location, and type of function-altering mutations were compared to ΔΔ<italic>G</italic> changes arising from all possible point mutations in the same enzymes. We found that mutations that modulate enzymatic functions are mostly destabilizing (average ΔΔ<italic>G</italic> = +0.9 kcal/mol), and are almost as destabilizing as the “average” mutation in these enzymes (+1.3 kcal/mol). Although their stability effects are not as dramatic as in key catalytic residues, mutations that modify the substrate binding pockets, and thus mediate new enzymatic specificities, place a larger stability burden than surface mutations that underline neutral, non-adaptive evolutionary changes. How are the destabilizing effects of functional mutations balanced to enable adaptation? Our analysis also indicated that many mutations that appear in directed evolution variants with no obvious role in the new function exert stabilizing effects that may compensate for the destabilizing effects of the crucial function-altering mutations. Thus, the evolution of new enzymatic activities, both in nature and in the laboratory, is dependent on the compensatory, stabilizing effect of apparently “silent” mutations in regions of the protein that are irrelevant to its function.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>To perform its function, a protein must fold into a complex, three-dimensional structure that is maintained by a network of interactions between its amino acid residues. Evolution of a new protein function will be driven by mutation of amino acids in key positions (<italic>new-function mutations</italic>). Such mutation can also hamper interactions that ensure the stability of a protein's fold—sometimes to a degree that renders the protein non-functional. Indeed, previous studies have noted that the evolution of new enzymatic functions is accompanied by significant losses in protein stability, suggesting a “tradeoff” between acquisition of new enzymatic functions and stability. But since most mutations are destabilizing, we sought to compare new-function mutations with other types of mutations. We performed a comprehensive analysis of the type, location, and stability effects of mutations that have conferred new enzymatic functions in laboratory evolution experiments. We found that stability changes (ΔΔ<italic>G</italic>) of new-function mutations are similar to those of all other mutations, but are weaker than those of mutations that characterize neutral evolutionary changes (mutations that accumulate with no change of structure and function). Our analysis also revealed the important role of neutral (i.e., “non-functional”) mutations in compensating for the destabilizing effects of the “new-function” mutations.</p></abstract><funding-group><funding-statement>N. T. is a recipient of an EMBO Short Term Fellowship. Research grants from the EU (through the BioModularH2 consortium), the Israel Ministry of Science and Technology, and the Estate of Fannie Sherr, are gratefully acknowledged</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>With the exception of unstructured protein domains, the integrity of a protein's structure and function is largely dependent on its thermodynamic stability. Evolutionary processes, be they neutral, or adaptive, involve the acquisition of mutations that may affect protein function and/or stability. For example, a mutation that endows a desirable new function, but severely undermines stability, will not become fixed. The relationship between mutational effects, function and stability is therefore crucial to our understanding not only of the evolutionary dynamics of proteins <xref ref-type="bibr" rid="pcbi.1000002-DePristo1">[1]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Bloom2">[6]</xref>, but also in engineering, designing, and evolving, novel enzymes in the laboratory <xref ref-type="bibr" rid="pcbi.1000002-Baltzer1">[7]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Bloom3">[12]</xref>.</p><p>Stability-function tradeoffs became originally evident in enzymes, particularly in the structural tension created by the arrangement of catalytic residues in active sites. From the point of view of overall protein stability, active site organization is inherently unfavorable for a number of reasons. Functional residues, which are generally polar or charged, are embedded in hydrophobic clefts <xref ref-type="bibr" rid="pcbi.1000002-Fersht1">[13]</xref>, sometimes with proximal like charges. Key catalytic residues often possess unfavorable backbone angles <xref ref-type="bibr" rid="pcbi.1000002-Ollis1">[14]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Herzberg1">[15]</xref>. Consequently, the substitution of an enzyme's key catalytic side chains (typically into alanine) can dramatically increase stability whilst obviously sacrificing activity <xref ref-type="bibr" rid="pcbi.1000002-Beadle1">[16]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Nagatani1">[23]</xref>.</p><p>Such observations (notwithstanding exceptions such as residues that contribute to both function and stability <xref ref-type="bibr" rid="pcbi.1000002-DiNardo1">[24]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Schindler1">[26]</xref>, and cases where enzyme stability can be increased without comprising function <xref ref-type="bibr" rid="pcbi.1000002-Lehmann1">[10]</xref>, <xref ref-type="bibr" rid="pcbi.1000002-Giver1">[27]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Takahashi1">[31]</xref>) led to the generally accepted principle of stability-function tradeoffs <xref ref-type="bibr" rid="pcbi.1000002-Beadle1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Schreiber1">[19]</xref> that was later extended to tradeoffs between <italic>new functions</italic> and stability <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>. However, as discussed below, we surmise that there exists a fundamental difference between mutations in key catalytic residues that relate to the well established stability-function tradeoff, and mutations that mediate the evolutionary divergence of new functions.</p><p>Enzymes evolve new functions via mutations that alter substrate specificity, typically by increasing the affinity and rates for weak promiscuous substrates. These changes involve mutational adjustments of the active site, its periphery, or even the “second” and “third shell” of residues that surround it, while maintaining the key catalytic residues intact. As shown below, in oppose to mutations in key catalytic residues that typically involve an exchange into alanine of a charged/polar residue within a hydrophobic surroundings, the type and location of new function mutations is far more diverse. As initially observed by Wang et al. <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Chen1">[33]</xref>, most mutations that confer new functions have been proven to be destabilizing (for recent examples see <xref ref-type="bibr" rid="pcbi.1000002-Bloom4">[34]</xref>). However, the generality of stability-function tradeoffs with regard to new functions should be addressed in view of the fact that, regardless of their relevance to function, <italic>most</italic> mutations are destabilizing <xref ref-type="bibr" rid="pcbi.1000002-Serrano1">[30]</xref>, <xref ref-type="bibr" rid="pcbi.1000002-GodoyRuiz1">[35]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Matthews1">[37]</xref>. Indeed, derivation of the ΔΔ<italic>G</italic> distributions of all possible mutations in a series of globular proteins using the experimentally validated FoldX algorithm <xref ref-type="bibr" rid="pcbi.1000002-Guerois1">[38]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Schymkowitz1">[39]</xref>) indicated that about 70% of mutations are destabilizing (ΔΔ<italic>G</italic>&gt;0 kcal/mol), and &gt;20% are significantly destabilizing (ΔΔ<italic>G</italic>≥2 kcal/mol) <xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. On the other hand, mutations that characterize neutral, non-adaptive changes (mutational drifts with no changes in protein function and structure) occur primarily on the surface, certainly at the first steps of sequence divergence <xref ref-type="bibr" rid="pcbi.1000002-Sasidharan1">[41]</xref>, and this subgroup of mutations is much less destabilizing (average ΔΔ<italic>G</italic> = 0.6 kcal/mol <xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. Thus, better understanding of how the emergence of new functions trades-off with protein stability requires a comparison of mutations that confer new protein functions to all other possible mutations in a protein, as well as to mutations that characterize neutral, non-adaptive changes.</p><p>With this in mind, we investigated a large set of mutations that were found in enzymes that acquired new substrate specificities in directed evolution experiments and clinical isolates (548 mutations in 22 different enzymes). We applied FoldX to compute the ΔΔ<italic>G</italic> values of these mutations, and compared the type (hydrophibicity/polarity), location (solvent accessibility and secondary structure assignment), and ΔΔ<italic>G</italic> values of these mutations with all possible point mutations in the same proteins. While realizing that the FoldX values are a prediction of limited accuracy, they do enable the examination the distributions of ΔΔ<italic>G</italic> values for a large set of proteins and mutations, and on the whole, these predictions show reasonable correlation with experimental data <xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. Thus, whilst the values for individual mutations can considerably deviate from the experimental values, the trends we observed are likely to be relevant <xref ref-type="bibr" rid="pcbi.1000002-Reichmann1">[42]</xref>.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Classification of Mutations</title><p>We systematically explored the directed evolution literature from 2003 to date for cases amenable to our analysis. The criteria included enzymes in which few, or more, mutations accumulated, and a new substrate specificity evolved in response, and that have a high resolution crystal structure (a list of the analyzed enzymes and mutations is available as <xref ref-type="supplementary-material" rid="pcbi.1000002.s002">Table S1</xref>). TEM-1 mutations observed in clinical isolates, and subsequently in laboratory evolution experiments, were also included in our analysis.</p><p>Variants isolated in directed evolution experiments and clinical isolates generally possess multiple mutations. Nevertheless, as with natural enzymes, only some mutations are directly related to the newly acquired function, while others are largely neutral. The mutations in the studied enzyme variants were therefore classified into two categories: (a) <italic>new-function</italic> mutations—i.e., mutations that confer the new function, and (b) <italic>other</italic> mutations—i.e., all mutations that accumulated in these variants alongside the adaptive mutations. We assigned mutations as <italic>new-function</italic> mutations by three criteria: (i) the mutation was the only mutation in the variant showing the new activity or selectivity; (ii) the mutation was identified by the authors as <italic>contributing</italic> to the new function; (iii) the mutation was conserved, or dominant, in all the variants isolated after several rounds of mutation and selection. <italic>Other</italic> mutations included nonessential mutations that were seen in only one of the isolated variants, or were shown to be irrelevant to the functional change. Using these criteria, we classified 246 mutations as “<italic>new-function</italic>” mutations, and 302 mutations as “<italic>other</italic>” mutations (<xref ref-type="supplementary-material" rid="pcbi.1000002.s003">Table S2</xref>).</p></sec><sec id="s2b"><title>Type and Location of the Mutations</title><p>The location and type of a mutated residue affects the stability changes induced by mutations in this residue. In particular, the distribution of ΔΔ<italic>G</italic> values differs significantly for surface <italic>vs.</italic> core residues. Thus, as the solvent accessibility (ASA) of a residue decreases, the destabilizing ΔΔ<italic>G</italic> values of its mutation increase <xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. It was therefore necessary to account for the location of “<italic>new-function</italic>” and “other” mutations and thus ensure a balanced comparison with all other possible mutations in residues of equivalent type and location.</p><sec id="s2b1"><title>Type of mutations</title><p>The key catalytic residues of enzymes are generally charged or polar <xref ref-type="bibr" rid="pcbi.1000002-Bartlett1">[43]</xref>. However, our analysis showed about 50% of <italic>new-function</italic> mutations involved changes in hydrophobic residues (<xref ref-type="fig" rid="pcbi-1000002-g001">Figure 1a</xref>). This proportion is very similar to that found for the <italic>other</italic> mutations, and indeed for <italic>all</italic> protein residues. The fraction of polar residues seems to slightly increased in <italic>new-function</italic> mutations, and a higher fraction of charged residues were exchanged by <italic>other</italic> mutations The latter correlates with the observation that other mutations tend to be in surface residues (see below). The fraction of hydrophobic residues seems to slightly increase after mutations in both the <italic>new-function</italic> (from 47% to 50%) and <italic>other</italic> mutations (from 47% to 48%) have been incorporated. This tendency might relate to biases in the mutagenesis methods employed <xref ref-type="bibr" rid="pcbi.1000002-Wong1">[44]</xref>. Overall, this analysis indicated that, in contrast to key catalytic residues where charged and polar residues dominate, the types of residues in which <italic>new-function</italic> mutations occur are distributed in a manner similar to the rest of the protein.</p><fig id="pcbi-1000002-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000002.g001</object-id><label>Figure 1</label><caption><title>Distribution of mutations with respect to residue type (a), and their location in secondary structural elements (b).</title><p>Noted are: <italic>all</italic> protein residues (referring to mutations attainable in all protein residues by single nucleotide exchanges); <italic>key catalytic</italic> residues (data adapted from Bartlett et al. <xref ref-type="bibr" rid="pcbi.1000002-Bartlett1">[43]</xref>); and residues in which mutations identified in directed evolution experiments occur, divided to <italic>new-function</italic> mutations, and <italic>other</italic> mutations, as explained in the text.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.g001" xlink:type="simple"/></fig></sec><sec id="s2b2"><title>Secondary structure</title><p>About 70% of the total residues in enzymes occur in secondary structures such as α-helices and β-sheets. The remaining 30% are found in random coils. In contrast, about 50% of active site residues are located in random coils <xref ref-type="bibr" rid="pcbi.1000002-Bartlett1">[43]</xref>. In accordance, the <italic>new-function</italic> mutations are more often found in random coils than in α-helices and β-sheets, and those proportions are similar to key catalytic residues (<xref ref-type="fig" rid="pcbi-1000002-g001">Figure 1b</xref>). <italic>Other mutations</italic> are found less in random coils than <italic>new-function mutations</italic>, closer to <italic>all</italic> mutations (<xref ref-type="fig" rid="pcbi-1000002-g001">Figure 1b</xref>). This supports the fact that the <italic>other mutations</italic> are not directly involved in the acquisition of new function.</p></sec><sec id="s2b3"><title>Solvent accessibility</title><p>In general, catalytic residues tend to be partially exposed to solvent <xref ref-type="bibr" rid="pcbi.1000002-Bartlett1">[43]</xref>. However, the ASA values of <italic>new-function</italic> mutations are distributed in a manner similar to all residues, whereas <italic>other</italic> mutations tend to locate more to the enzyme surface than its core (<xref ref-type="fig" rid="pcbi-1000002-g002">Figure 2</xref>), thus indicating that <italic>other</italic> mutations are involved in a different process, most likely neutral, non-adaptive evolution. Contrary, <italic>new-function</italic> mutations are distributed similarly to all other mutations, and with significantly more mutations in the core (ASA&lt;0.25) than observed with <italic>other</italic> mutations, thus implying their role in the acquisition of new functions, and their larger destabilizing effects.</p><fig id="pcbi-1000002-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000002.g002</object-id><label>Figure 2</label><caption><title>Solvent accessibility (ASA) of the mutated residues.</title><p>ASA values were calculated with “ASA view” (<ext-link ext-link-type="uri" xlink:href="http://www.netasa.org/asaview/" xlink:type="simple">http://www.netasa.org/asaview/</ext-link>). Plotted are the distributions for <italic>all</italic> protein residues, and residues in which <italic>new-function</italic> mutations, and <italic>other</italic> mutations occur.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.g002" xlink:type="simple"/></fig><p>Overall, therefore, the <italic>new-function</italic> mutations are in quite similar types and positions as all residues, with the exception that they have a greater tendency to be located on random coils. The <italic>other mutations</italic> show a strong tendency to be located on the surface.</p></sec></sec><sec id="s2c"><title>The ΔΔ<italic>G</italic> Distributions</title><p>The stability effects of mutations (ΔΔ<italic>G</italic>) were computed with the protein design software FoldX, whose force-field is based on empirical energy terms correlated with experimental ΔΔ<italic>G</italic> measurements <xref ref-type="bibr" rid="pcbi.1000002-Guerois1">[38]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Schymkowitz1">[39]</xref>. In a previous work, we found that ΔΔ<italic>G</italic> distributions of all possible mutations in globular, monomeric, single domain proteins of ≤340 amino acids can be described by a universal bi-Gaussian function with only one free parameter (the protein's chain length) <xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. The vast majority of enzymes analyzed in the study, especially those that possess large number of mutations, meet the above size criterion (<xref ref-type="table" rid="pcbi-1000002-t001">Table 1</xref>). We have therefore compared the distribution of ΔΔ<italic>G</italic> values for <italic>new-function</italic> mutations, and <italic>other</italic> mutations, with the distributions for all possible mutations that are attainable by single nucleotide substitutions from the protein's wild type sequence (<italic>all mutations</italic>). Although certain variants carry multiple mutations, we based our tradeoff analysis on the ΔΔ<italic>G</italic> values of individual mutations. In nature, and frequently in the lab, function-altering mutations tend to accumulate one at a time, and are combined only in subsequent generations. Indeed, in most cases, ΔΔ<italic>G</italic> and functional effects of multiple mutations are largely additive <xref ref-type="bibr" rid="pcbi.1000002-Serrano1">[30]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Zhang1">[45]</xref>.</p><table-wrap id="pcbi-1000002-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000002.t001</object-id><label>Table 1</label><caption><title>Summary of average ΔΔ<italic>G</italic> and ASA values of mutations.</title></caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000002-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" colspan="2" rowspan="1">Name</td><td align="left" colspan="3" rowspan="1">All residues</td><td align="left" colspan="3" rowspan="1"><italic>New-function</italic> mutations</td><td align="left" colspan="3" rowspan="1"><italic>Other</italic> mutations</td></tr><tr><td align="left" colspan="1" rowspan="1">Common name</td><td align="left" colspan="1" rowspan="1">Abbreviation</td><td align="left" colspan="1" rowspan="1">ΔΔ<italic>G</italic></td><td align="left" colspan="1" rowspan="1">ASA</td><td align="left" colspan="1" rowspan="1"># of mutations analyzed</td><td align="left" colspan="1" rowspan="1">ΔΔ<italic>G</italic></td><td align="left" colspan="1" rowspan="1">ASA</td><td align="left" colspan="1" rowspan="1"># of mutations analyzed</td><td align="left" colspan="1" rowspan="1">ΔΔ<italic>G</italic></td><td align="left" colspan="1" rowspan="1">ASA</td><td align="left" colspan="1" rowspan="1"># of mutations analyzed</td></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Aspartate aminotransfrase</td><td align="left" colspan="1" rowspan="1">AspATs</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.77±1.26</td><td align="left" colspan="1" rowspan="1">0.35±0.29</td><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">-0.08±1.46</td><td align="left" colspan="1" rowspan="1">0.31±0.30</td><td align="left" colspan="1" rowspan="1">85</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>Burkholderia gladioli</italic> esterase EstB</td><td align="left" colspan="1" rowspan="1">EstB</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.15±0.98</td><td align="left" colspan="1" rowspan="1">0.20±0.20</td><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">0.44±0.58</td><td align="left" colspan="1" rowspan="1">0.44±0.20</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">Cytocrome c peroxidase</td><td align="left" colspan="1" rowspan="1">CCP</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.91±1.69</td><td align="left" colspan="1" rowspan="1">0.42±0.40</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">0.36±1.71</td><td align="left" colspan="1" rowspan="1">0.44±0.28</td><td align="left" colspan="1" rowspan="1">25</td></tr><tr><td align="left" colspan="1" rowspan="1">Dienelactone hydrolase</td><td align="left" colspan="1" rowspan="1">DLH</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.33±0.87</td><td align="left" colspan="1" rowspan="1">0.19±0.22</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">0.70±1.35</td><td align="left" colspan="1" rowspan="1">0.34±0.13</td><td align="left" colspan="1" rowspan="1">6</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>E. Coli</italic> dihydrofolate reductase</td><td align="left" colspan="1" rowspan="1">DHFR</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.61±2.26</td><td align="left" colspan="1" rowspan="1">0.32±0.28</td><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">0.69±1.62</td><td align="left" colspan="1" rowspan="1">0.39±0.25</td><td align="left" colspan="1" rowspan="1">8</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>E. coli</italic> Glucosamine synthase</td><td align="left" colspan="1" rowspan="1">GlmS</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.32±2.20</td><td align="left" colspan="1" rowspan="1">0.26±0.43</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">0.56±0.80</td><td align="left" colspan="1" rowspan="1">0.53±0.32</td><td align="left" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>E. coli</italic> KDPG aldolase</td><td align="left" colspan="1" rowspan="1">KDPG aldolase</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.83±1.62</td><td align="left" colspan="1" rowspan="1">0.34±0.25</td><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Extradiol dioxygenase</td><td align="left" colspan="1" rowspan="1">DoxG</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.85±2.10</td><td align="left" colspan="1" rowspan="1">0.06±0.07</td><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">0.06±1.55</td><td align="left" colspan="1" rowspan="1">0.39±0.31</td><td align="left" colspan="1" rowspan="1">10</td></tr><tr><td align="left" colspan="1" rowspan="1">Human carbonic anhydrase II</td><td align="left" colspan="1" rowspan="1">CAII</td><td align="left" colspan="1" rowspan="1">1.44±2.03</td><td align="left" colspan="1" rowspan="1">0.30±0.29</td><td align="left" colspan="1" rowspan="1">1539</td><td align="left" colspan="1" rowspan="1">0.50±0.82</td><td align="left" colspan="1" rowspan="1">0.11±0.12</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.35</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Human Glutathione transderase</td><td align="left" colspan="1" rowspan="1">hGST</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2.08±1.77</td><td align="left" colspan="1" rowspan="1">0.34±0.25</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">0.74±0.97</td><td align="left" colspan="1" rowspan="1">0.31±0.29</td><td align="left" colspan="1" rowspan="1">39</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>Neisseria polysaccharea</italic> amylosucrase</td><td align="left" colspan="1" rowspan="1">Amylosucrase</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.53±1.65</td><td align="left" colspan="1" rowspan="1">0.28±0.27</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">1.04±0.74</td><td align="left" colspan="1" rowspan="1">0.24±0.30</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">OmpT protease</td><td align="left" colspan="1" rowspan="1">OmpT protease</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-0.79±6.32</td><td align="left" colspan="1" rowspan="1">0.06±0.07</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">-0.11±1.37</td><td align="left" colspan="1" rowspan="1">0.50±0.21</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">OPDA phosphotriesterase</td><td align="left" colspan="1" rowspan="1">OPDA</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-0.75±2.40</td><td align="left" colspan="1" rowspan="1">0.30±0.18</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><italic>P. aeruginosa</italic> Lipase</td><td align="left" colspan="1" rowspan="1">Lipase</td><td align="left" colspan="1" rowspan="1">1.13±1.85</td><td align="left" colspan="1" rowspan="1">0.27±0.27</td><td align="left" colspan="1" rowspan="1">1694</td><td align="left" colspan="1" rowspan="1">0.83±1.36</td><td align="left" colspan="1" rowspan="1">0.36±0.30</td><td align="left" colspan="1" rowspan="1">46</td><td align="left" colspan="1" rowspan="1">0.14±1.27</td><td align="left" colspan="1" rowspan="1">0.33±0.24</td><td align="left" colspan="1" rowspan="1">9</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>P. diminuta</italic> phosphotriesterase</td><td align="left" colspan="1" rowspan="1">PTE</td><td align="left" colspan="1" rowspan="1">n.d.</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-0.09±1.66</td><td align="left" colspan="1" rowspan="1">0.21±0.19</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">0.20±1.63</td><td align="left" colspan="1" rowspan="1">0.31±0.26</td><td align="left" colspan="1" rowspan="1">10</td></tr><tr><td align="left" colspan="1" rowspan="1">P450 2A6</td><td align="left" colspan="1" rowspan="1">P450 2A6</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.30±0.41</td><td align="left" colspan="1" rowspan="1">0.11±0.05</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">PTE homology protein</td><td align="left" colspan="1" rowspan="1">PHP</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2.57±3.37</td><td align="left" colspan="1" rowspan="1">0.22±0.21</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">0.43±0.63</td><td align="left" colspan="1" rowspan="1">0.34±0.48</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">Recombinant serum paraoxonase 1</td><td align="left" colspan="1" rowspan="1">rePON 1</td><td align="left" colspan="1" rowspan="1">1.39±1.76</td><td align="left" colspan="1" rowspan="1">0.28±0.28</td><td align="left" colspan="1" rowspan="1">1936</td><td align="left" colspan="1" rowspan="1">1.21±1.21</td><td align="left" colspan="1" rowspan="1">0.25±0.21</td><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1">0.47±1.65</td><td align="left" colspan="1" rowspan="1">0.47±0.31</td><td align="left" colspan="1" rowspan="1">48</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic>S. clavuligerus</italic> deacetoxycephalosporin C synthase</td><td align="left" colspan="1" rowspan="1">DAOCS</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.60±1.00</td><td align="left" colspan="1" rowspan="1">0.32±0.30</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">0.05±0.88</td><td align="left" colspan="1" rowspan="1">0.31±0.34</td><td align="left" colspan="1" rowspan="1">10</td></tr><tr><td align="left" colspan="1" rowspan="1">Tagatose-1,6-bisphosphate aldolase</td><td align="left" colspan="1" rowspan="1">TBA</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.01±1.04</td><td align="left" colspan="1" rowspan="1">0.13±0.12</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">1.48</td><td align="left" colspan="1" rowspan="1">0.10</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">TEM-1 β-lactamase</td><td align="left" colspan="1" rowspan="1">TEM-1</td><td align="left" colspan="1" rowspan="1">1.14±1.69</td><td align="left" colspan="1" rowspan="1">0.28±0.28</td><td align="left" colspan="1" rowspan="1">1546</td><td align="left" colspan="1" rowspan="1">1.27±1.59</td><td align="left" colspan="1" rowspan="1">0.24±0.26</td><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">0.20±1.80</td><td align="left" colspan="1" rowspan="1">0.30±0.28</td><td align="left" colspan="1" rowspan="1">30</td></tr><tr><td align="left" colspan="1" rowspan="1">Vanillyl-alcohol oxidase</td><td align="left" colspan="1" rowspan="1">VAO</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1">n.d</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-0.03±2.27</td><td align="left" colspan="1" rowspan="1">0.02±0.02</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">0.99±1.55</td><td align="left" colspan="1" rowspan="1">0.23±0.10</td><td align="left" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>total</bold></td><td align="left" colspan="1" rowspan="1"><bold>0.86±1.65</bold></td><td align="left" colspan="1" rowspan="1"><bold>0.28±0.26</bold></td><td align="left" colspan="1" rowspan="1"><bold>246</bold></td><td align="left" colspan="1" rowspan="1"><bold>0.39±1.37</bold></td><td align="left" colspan="1" rowspan="1"><bold>0.39±0.29</bold></td><td align="left" colspan="1" rowspan="1"><bold>302</bold></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>Additional details regarding the analyzed proteins are provided in Supplementary <xref ref-type="supplementary-material" rid="pcbi.1000002.s002">Table 1</xref>.</p></fn><fn id="nt102"><label/><p>n.d. – not determined.</p></fn></table-wrap-foot></table-wrap><p>In all 22 enzymes analyzed here, the average ΔΔ<italic>G</italic> values for <italic>new-function</italic> mutations were found to be comparable to those of <italic>all</italic> mutations (<xref ref-type="table" rid="pcbi-1000002-t001">Table 1</xref>). Overall, the distributions of ΔΔ<italic>G</italic> values for <italic>new-function</italic> mutations are nearly identical to those of <italic>all mutations</italic>, although there are significantly fewer highly destabilizing mutations (ΔΔ<italic>G</italic>&gt;3 kcal/mol) in <italic>new-function</italic> mutations (8%) than in <italic>all mutations</italic> (15%) (<xref ref-type="fig" rid="pcbi-1000002-g003">Figure 3</xref>). This observation is expected as highly destabilizing mutations undermine the enzyme's structure and are therefore eliminated by selection, and is consistent with the analysis of ΔΔ<italic>G</italic> values of mutations that accumulated in a neutral drift under strong purifying selection (ΔΔ<italic>G</italic>≤3 kcal/mol) <xref ref-type="bibr" rid="pcbi.1000002-Bershtein1">[46]</xref>.</p><fig id="pcbi-1000002-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000002.g003</object-id><label>Figure 3</label><caption><title>The ΔΔ<italic>G</italic> distributions of <italic>new-function</italic> mutations in comparison with <italic>other</italic> mutations and <italic>all</italic> possible mutations.</title><p>The ΔΔ<italic>G</italic> values of mutations were computed by FoldX as described <xref ref-type="bibr" rid="pcbi.1000002-Guerois1">[38]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. The resulting values were presented in histograms by classifying 25 bins, each 1.0 kcal/mol wide.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.g003" xlink:type="simple"/></fig><p>Because <italic>new-function</italic> mutations are distributed in different secondary structure elements than the rest of the protein (<xref ref-type="fig" rid="pcbi-1000002-g001">Figure 1b</xref>), their location might bias ΔΔ<italic>G</italic> distributions. To ameliorate this we adjusted the ΔΔ<italic>G</italic> distributions of <italic>all</italic> mutations to have the same proportion of secondary structure elements as <italic>new-function</italic> mutations by comparing the ΔΔ<italic>G</italic> distributions of random coils, α-helices, and β-sheets, of four of the studied enzymes (PON, CAII, Lipase, and TEM-1). The ΔΔ<italic>G</italic> values of β-sheets appeared to be more destabilizing than those of random coils and α-helices (<xref ref-type="supplementary-material" rid="pcbi.1000002.s001">Figure S1</xref>), as previously observed <xref ref-type="bibr" rid="pcbi.1000002-Guo1">[47]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Loh1">[48]</xref>. Nevertheless, the overall effect of this adjustment was minor, and the distributions of ΔΔ<italic>G</italic> values for <italic>new-function</italic> mutations remained nearly identical to those of <italic>all</italic> mutations (<xref ref-type="supplementary-material" rid="pcbi.1000002.s001">Figure S1</xref>).</p><p>The overall picture that emerges is that the <italic>new-function</italic> mutations are distributed as all other mutations. The majority of both <italic>all-</italic> and <italic>new-function</italic> mutations are destabilizing (43% of mutations exhibit ΔΔ<italic>G</italic> values higher than 1 kcal/mol), and a significant fraction of mutations are actually stabilizing (7% of mutations exhibit ΔΔ<italic>G</italic> &lt;−1 kcal/mol). Thus, the mutations associated with the acquisition of new functions are as destabilizing as the “average mutation”.</p><p>However, the <italic>other</italic> mutations (those that accumulated in variants alongside function altering mutations) are distributed in a different manner. They contain many more neutral, and stabilizing mutations, and fewer destabilizing mutations (30% &gt;1 kcal/mol) than <italic>all-</italic> and <italic>new-function</italic> mutations (<xref ref-type="fig" rid="pcbi-1000002-g003">Figure 3</xref>). This distribution indicates that <italic>other</italic> mutations largely reflect neutral, non-adaptive evolution, whereby destabilizing mutations are purged out. Nevertheless, the significantly higher fraction of stabilizing mutations 38% &lt;0 kcal/mol <italic>vs.</italic> 21% in <italic>all</italic> mutations) indicates that <italic>other</italic> mutations can also play a role in increasing protein stability, and thereby compensate for the destabilizing effects of the <italic>new-function</italic> mutations that drive the adaptive process.</p></sec></sec><sec id="s3"><title>Discussion</title><sec id="s3a"><title>Do New Functions Tradeoff with Stability?</title><p>It is widely accepted that active site construction is thermodynamically unfavorable. Thus, many active site mutations, and the removal of key catalytic residues in particular, dramatically stabilize enzymes at the expense of activity <xref ref-type="bibr" rid="pcbi.1000002-Beadle1">[16]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Nagatani1">[23]</xref>. By the same logic, stability is likely to be compromised when enzymes acquire new activities by evolutionary processes. To date, this hypothesis was supported by several sets of experimental data, but lacked a comprehensive analysis that compares the distribution of ΔΔ<italic>G</italic> effects of mutations that drive the acquisition of new functions over all other mutations. A comprehensive analysis of this kind can only be performed computationally simply because of the vast number of mutations that need to be analyzed. Although the computed FoldX values are of limited accuracy, they do enable the examination the distributions of ΔΔ<italic>G</italic> values for a large set of proteins and mutations, and on the whole, these predictions show reasonable correlation with experimental data <xref ref-type="bibr" rid="pcbi.1000002-Guerois1">[38]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. The computed average of ΔΔ<italic>G</italic> values for mutation endowing new functions (+0.9 kcal/mol) is also within the range of experimental values obtained for such mutations; the average of ΔΔ<italic>G</italic> value for six mutants that conferred new function in TEM-1 β-lactamase is +1.7 kcal/mol (+0.22 to +4.04 kcal/mol) <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>.</p><p>The computational analysis indicated that <italic>new-function</italic> mutations are as destabilizing as mutations in other parts of the protein, and thus, there seems to be no distinct tradeoff between new functions and stability. Sanchez et al. have recently reached a similar conclusion by analyzing the correlation between ΔΔ<italic>G</italic> values and the frequency of mutations in functional sites of natural proteins. They found that selection for function is overruling selection for stability, but observed no anti-correlation between function and stability <xref ref-type="bibr" rid="pcbi.1000002-Sanchez1">[49]</xref>. The above said, we also found that the type and location of new-function mutations are almost indistinguishable from the rest of the protein (other than a tendency to locate to random coils). That the solvent accessibility of <italic>new-function</italic> mutations is distributed as the rest of the protein (<xref ref-type="fig" rid="pcbi-1000002-g002">Figure 2</xref>) is indicative of their special nature. Neutral (non-adaptive) drift (i.e., the gradual accumulation of mutations while retaining function or structural) initially involves surface residues <xref ref-type="bibr" rid="pcbi.1000002-Sasidharan1">[41]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Goldman1">[50]</xref>, and thus minor stability changes. This is also reflected in the nature of the <italic>other</italic> mutations that tend to be on the surface and exhibit minor stability changes, and even stabilizing, compensatory effects as discussed below. In contrast, the acquisition of new-function involves also core residues, and is therefore more demanding in stability terms than a neutral drift. In that respect, i.e., when comparing neutral, to adaptive evolutionary changes, one could say that new function does trade-off with stability.</p><p>The tendency of <italic>new-function</italic> mutations to locate to random coils is also in accordance with the notion that the routes leading to new functions do not usually involve modification of either the enzyme's scaffold or key catalytic residues, but rather involve multiple, and often subtle, changes in loops that comprise the substrate binding pocket <xref ref-type="bibr" rid="pcbi.1000002-Aharoni1">[51]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Tawfik1">[53]</xref>. Indeed, directed evolution experiments indicated that most <italic>new-function</italic> mutations are located relatively far from the key catalytic residues, often being found in the periphery of the active site <xref ref-type="bibr" rid="pcbi.1000002-Aharoni1">[51]</xref>, <xref ref-type="bibr" rid="pcbi.1000002-Oue1">[54]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Morley1">[56]</xref>. Thus, the changes that drive divergence towards new functions do not usually involve the incorporation of the same type of thermodynamically unfavorable active site residues that provide the main catalytic function of the enzyme. Indeed, in enzyme superfamilies, despite a wealth of different reactions and substrates, scaffolds and key catalytic residues remain unchanged <xref ref-type="bibr" rid="pcbi.1000002-Gerlt1">[57]</xref>.</p><p>Our analysis therefore indicates that the two classes of residues—i.e., key catalytic residues, and new function residues, are subject to different rules. Key catalytic residues are inherently, and dramatically destabilizing, and therefore exhibit distinct function-stability tradeoffs. In contrast, new function residues as destabilizing as the “average” protein mutation, although they appear to be more destabilizing than mutations that occur during non-adaptive evolutionary changes.</p></sec><sec id="s3b"><title>Protein Stability and the Evolution of New Functions</title><p>Although our findings indicate no specific tradeoffs between new function and stability, at the end of the day, the majority of new-function mutations are destabilizing. Furthermore, the fact that there are fewer highly destabilizing mutations amongst “successful” <italic>new-function</italic> mutations (<xref ref-type="fig" rid="pcbi-1000002-g003">Figure 3</xref>) is another manifestation of the notion that stability severely constrains adaptive evolution (i.e., the acquisition of new functions) <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Bloom4">[34]</xref>. Thus, although in principle new function mutations can be highly destabilizing, similar to mutations in key catalytic residues, such detrimental mutations are not commonly seen in proteins evolving new functions, either in nature, or in the laboratory. It also follows, that increasing the initial stability of the starting point enzyme will enable the subsequent acquisition of function altering mutations that are otherwise not tolerated <xref ref-type="bibr" rid="pcbi.1000002-DePristo1">[1]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Camps1">[2]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Bloom2">[6]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Bloom4">[34]</xref>,<xref ref-type="bibr" rid="pcbi.1000002-Besenmatter1">[58]</xref>.</p><p>The destabilizing effects of new function mutations should also be considered in view of the fact that the acquisition of new functions typically depends on multiple mutations. Indeed, proteins posses a threshold of stability that can initially buffer some of the deleterious effects of destabilizing mutations. Once this threshold is exhausted, however, protein “fitness” (i.e., expression and activity levels) is rapidly lost. This is manifested in the non-additive, or negative, epistatic effects of mutations on protein fitness—despite their ΔΔ<italic>G</italic> effects being largely additive <xref ref-type="bibr" rid="pcbi.1000002-Bershtein1">[46]</xref>. Thus, as the adaptive process continues, proteins must regain stability through other mutations <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>. This scenario is evident in the role of Met181Thr mutation played in the evolution of TEM-1—(a global suppressor found in clinical isolates and directed evolution experiments, stabilizing −2.67 kcal/mol) towards the hydrolysis of a third-generation antibiotic <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>. Indeed, our analysis indicates that many of the <italic>other</italic> mutations seen in directed evolution experiments might play an essential role in compensating for loss of stability, and are thus involved in the process despite having no direct role in altering the activity of the evolving enzyme.</p><p>Thus, despite the fact that no specific activity-stability tradeoffs are associated with the acquisition of new functions, it appears that that the pattern of stability loss and restoration does underpin the evolution of new enzyme activities as previously noted <xref ref-type="bibr" rid="pcbi.1000002-Wang1">[32]</xref>. It is clear therefore, that a more profound understanding of the dynamics and mechanism of stability restoration, and the ability to reproduce them in the laboratory, might be the key to achieving more rapid and effective enzyme evolution.</p></sec></sec><sec id="s4"><title>Methods</title><p>We search the ISI web of science database for all articles containing: “directed evolution” and enzyme. The search included these terms within title, abstract, and key words, for the period of 2003 till the end of September 2007. The resulting articles were further screened for all cases amenable to our analysis; the criteria being: (i) crystal structure of the evolved enzyme at ≤2.5 Å resolution; (ii) directed evolution aimed at new substrate specificity, or catalytic activity, but not higher stability and other stability related properties such as tolerance to organic solvents; (iii) a detailed description of more than few mutations related to functional changes, typically including the description of single mutants to enable a distinction between <italic>new-function</italic> and <italic>other</italic> mutations. The screen resulted in a total of 22 enzymes and 548 mutations that were further analyzed.</p><p>The thermodynamic stability changes of mutations were computed using the protein design tool FoldX (version 2.52). We followed a four-step procedure as described in detail previously <xref ref-type="bibr" rid="pcbi.1000002-Guerois1">[38]</xref>–<xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. First, 3D structures were taken from the Protein Data Bank (PDB accession codes are listed in <xref ref-type="supplementary-material" rid="pcbi.1000002.s002">Table S1</xref>) were optimized using the repair function of FoldX. Second, structures corresponding to each of the single point mutants (including self-mutated structures) were generated by the repair position scan function of FoldX. Third, the energies for these structures were calculated using the energy calculation function of FoldX. Finally, the ΔΔ<italic>G</italic> of mutations were obtained by comparing the energy values of the mutant structure with those of the wild type structures. The energy values obtained by FoldX were converted to realistic values based on a normalization function obtained by fitting the experimental and computed data (ΔΔ<italic>G<sup>experiment</sup></italic> = (ΔΔ<italic>G<sup>FoldX</sup></italic>+0.078)/1.14) <xref ref-type="bibr" rid="pcbi.1000002-Tokuriki1">[40]</xref>. The ASA value of each amino acid residue was calculated by the web server program “ASA view” (<ext-link ext-link-type="uri" xlink:href="http://www.netasa.org/asaview/" xlink:type="simple">http://www.netasa.org/asaview/</ext-link>). The ΔΔ<italic>G</italic> values obtained by FoldX were classified to 25 bins, each 1.0 kcal/mol wide, from −10 kcal/mol to 15 kcal/mol (all possible mutations with ΔΔ<italic>G</italic>&gt;14 kcal/mol were classified into the 14–15 kcal/mol bin, and mutations with ΔΔ<italic>G</italic>&lt;−9 kcal/mol into the (−10)–(−9) bin). The number of mutations in each bin was counted to make the distribution of ΔΔ<italic>G</italic>.</p></sec><sec id="s5"><title>Supporting Information</title><supplementary-material id="pcbi.1000002.s001" mimetype="application/postscript" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.s001" xlink:type="simple"><label>Figure S1</label><caption><p>The difference of C distribution with secondary structure propensity. (A) The ΔΔ<italic>G</italic> distribution of each secondary structure. (B) The composed ΔΔ<italic>G</italic> distribution according to the secondary structure propensity of new-function mutations (<xref ref-type="fig" rid="pcbi-1000002-g001">Figure 1b</xref>) comparing with new-function mutations and all residues.</p><p>(0.53 MB EPS)</p></caption></supplementary-material><supplementary-material id="pcbi.1000002.s002" mimetype="application/x-excel" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.s002" xlink:type="simple"><label>Table S1</label><caption><p>Summary of enzymes.</p><p>(0.04 MB XLS)</p></caption></supplementary-material><supplementary-material id="pcbi.1000002.s003" mimetype="application/x-excel" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000002.s003" xlink:type="simple"><label>Table S2</label><caption><p>Point mutations included in the study.</p><p>(0.13 MB XLS)</p></caption></supplementary-material></sec></body><back><ack><p>We are grateful to Lindsay D. Eltis, Pascal Fortin, and Jeff Bolin for their donation of 3D structure of Extradiol dioxygenase.</p></ack><ref-list><title>References</title><ref id="pcbi.1000002-DePristo1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>DePristo</surname><given-names>MA</given-names></name><name name-style="western"><surname>Weinreich</surname><given-names>DM</given-names></name><name name-style="western"><surname>Hartl</surname><given-names>DL</given-names></name></person-group>             <year>2005</year>             <article-title>Missense meanderings in sequence space: a biophysical view of protein evolution.</article-title>             <source>Nat Rev Genet</source>             <volume>6</volume>             <fpage>678</fpage>             <lpage>687</lpage>          </element-citation></ref><ref id="pcbi.1000002-Camps1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Camps</surname><given-names>M</given-names></name><name name-style="western"><surname>Herman</surname><given-names>A</given-names></name><name name-style="western"><surname>Loh</surname><given-names>E</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>LA</given-names></name></person-group>             <year>2007</year>             <article-title>Genetic constraints on protein evolution.</article-title>             <source>Crit Rev Biochem Mol Biol</source>             <volume>42</volume>             <fpage>313</fpage>             <lpage>326</lpage>          </element-citation></ref><ref id="pcbi.1000002-Pal1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>C</given-names></name><name name-style="western"><surname>Papp</surname><given-names>B</given-names></name><name name-style="western"><surname>Lercher</surname><given-names>MJ</given-names></name></person-group>             <year>2006</year>             <article-title>An integrated view of protein evolution.</article-title>             <source>Nat Rev Genet</source>             <volume>7</volume>             <fpage>337</fpage>             <lpage>348</lpage>          </element-citation></ref><ref id="pcbi.1000002-Poelwijk1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Poelwijk</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Kiviet</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Weinreich</surname><given-names>DM</given-names></name><name name-style="western"><surname>Tans</surname><given-names>SJ</given-names></name></person-group>             <year>2007</year>             <article-title>Empirical fitness landscapes reveal accessible evolutionary paths.</article-title>             <source>Nature</source>             <volume>445</volume>             <fpage>383</fpage>             <lpage>386</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bloom1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bloom</surname><given-names>JD</given-names></name><name name-style="western"><surname>Silberg</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Wilke</surname><given-names>CO</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>DA</given-names></name><name name-style="western"><surname>Adami</surname><given-names>C</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Thermodynamic prediction of protein neutrality.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>102</volume>             <fpage>606</fpage>             <lpage>611</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bloom2"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bloom</surname><given-names>JD</given-names></name><name name-style="western"><surname>Raval</surname><given-names>A</given-names></name><name name-style="western"><surname>Wilke</surname><given-names>CO</given-names></name></person-group>             <year>2007</year>             <article-title>Thermodynamics of neutral protein evolution.</article-title>             <source>Genetics</source>             <volume>175</volume>             <fpage>255</fpage>             <lpage>266</lpage>          </element-citation></ref><ref id="pcbi.1000002-Baltzer1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Baltzer</surname><given-names>L</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>J</given-names></name></person-group>             <year>2001</year>             <article-title>Emerging principles of de novo catalyst design.</article-title>             <source>Curr Opin Biotechnol</source>             <volume>12</volume>             <fpage>355</fpage>             <lpage>360</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bolon1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bolon</surname><given-names>DN</given-names></name><name name-style="western"><surname>Voigt</surname><given-names>CA</given-names></name><name name-style="western"><surname>Mayo</surname><given-names>SL</given-names></name></person-group>             <year>2002</year>             <article-title>De novo design of biocatalysts.</article-title>             <source>Curr Opin Chem Biol</source>             <volume>6</volume>             <fpage>125</fpage>             <lpage>129</lpage>          </element-citation></ref><ref id="pcbi.1000002-Butterfoss1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Butterfoss</surname><given-names>GL</given-names></name><name name-style="western"><surname>Kuhlman</surname><given-names>B</given-names></name></person-group>             <year>2006</year>             <article-title>Computer-based design of novel protein structures.</article-title>             <source>Annu Rev Biophys Biomol Struct</source>             <volume>35</volume>             <fpage>49</fpage>             <lpage>65</lpage>          </element-citation></ref><ref id="pcbi.1000002-Lehmann1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lehmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Wyss</surname><given-names>M</given-names></name></person-group>             <year>2001</year>             <article-title>Engineering proteins for thermostability: the use of sequence alignments versus rational design and directed evolution.</article-title>             <source>Curr Opin Biotechnol</source>             <volume>12</volume>             <fpage>371</fpage>             <lpage>375</lpage>          </element-citation></ref><ref id="pcbi.1000002-vandenBurg1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>van den Burg</surname><given-names>B</given-names></name><name name-style="western"><surname>Eijsink</surname><given-names>VG</given-names></name></person-group>             <year>2002</year>             <article-title>Selection of mutations for increased protein stability.</article-title>             <source>Curr Opin Biotechnol</source>             <volume>13</volume>             <fpage>333</fpage>             <lpage>337</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bloom3"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bloom</surname><given-names>JD</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>MM</given-names></name><name name-style="western"><surname>Meinhold</surname><given-names>P</given-names></name><name name-style="western"><surname>Otey</surname><given-names>CR</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>D</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Evolving strategies for enzyme engineering.</article-title>             <source>Curr Opin Struct Biol</source>             <volume>15</volume>             <fpage>447</fpage>             <lpage>452</lpage>          </element-citation></ref><ref id="pcbi.1000002-Fersht1"><label>13</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Fersht</surname><given-names>AR</given-names></name></person-group>             <year>1999</year>             <source>Structure and Mechanism in Protein Science: a Guide to Enzyme Catalysis and Protein Folding</source>             <publisher-loc>New York</publisher-loc>             <publisher-name>W. H. Freeman</publisher-name>          </element-citation></ref><ref id="pcbi.1000002-Ollis1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ollis</surname><given-names>DL</given-names></name><name name-style="western"><surname>Cheah</surname><given-names>E</given-names></name><name name-style="western"><surname>Cygler</surname><given-names>M</given-names></name><name name-style="western"><surname>Dijkstra</surname><given-names>B</given-names></name><name name-style="western"><surname>Frolow</surname><given-names>F</given-names></name><etal/></person-group>             <year>1992</year>             <article-title>The alpha/beta hydrolase fold.</article-title>             <source>Protein Eng</source>             <volume>5</volume>             <fpage>197</fpage>             <lpage>211</lpage>          </element-citation></ref><ref id="pcbi.1000002-Herzberg1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Herzberg</surname><given-names>O</given-names></name><name name-style="western"><surname>Moult</surname><given-names>J</given-names></name></person-group>             <year>1991</year>             <article-title>Analysis of the steric strain in the polypeptide backbone of protein molecules.</article-title>             <source>Proteins</source>             <volume>11</volume>             <fpage>223</fpage>             <lpage>229</lpage>          </element-citation></ref><ref id="pcbi.1000002-Beadle1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Beadle</surname><given-names>BM</given-names></name><name name-style="western"><surname>Shoichet</surname><given-names>BK</given-names></name></person-group>             <year>2002</year>             <article-title>Structural bases of stability-function tradeoffs in enzymes.</article-title>             <source>J Mol Biol</source>             <volume>321</volume>             <fpage>285</fpage>             <lpage>296</lpage>          </element-citation></ref><ref id="pcbi.1000002-Meiering1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Meiering</surname><given-names>EM</given-names></name><name name-style="western"><surname>Serrano</surname><given-names>L</given-names></name><name name-style="western"><surname>Fersht</surname><given-names>AR</given-names></name></person-group>             <year>1992</year>             <article-title>Effect of active site residues in barnase on activity and stability.</article-title>             <source>J Mol Biol</source>             <volume>225</volume>             <fpage>585</fpage>             <lpage>589</lpage>          </element-citation></ref><ref id="pcbi.1000002-Shoichet1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shoichet</surname><given-names>BK</given-names></name><name name-style="western"><surname>Baase</surname><given-names>WA</given-names></name><name name-style="western"><surname>Kuroki</surname><given-names>R</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>BW</given-names></name></person-group>             <year>1995</year>             <article-title>A relationship between protein stability and protein function.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>92</volume>             <fpage>452</fpage>             <lpage>456</lpage>          </element-citation></ref><ref id="pcbi.1000002-Schreiber1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schreiber</surname><given-names>G</given-names></name><name name-style="western"><surname>Buckle</surname><given-names>AM</given-names></name><name name-style="western"><surname>Fersht</surname><given-names>AR</given-names></name></person-group>             <year>1994</year>             <article-title>Stability and function: two constraints in the evolution of barstar and other proteins.</article-title>             <source>Structure</source>             <volume>2</volume>             <fpage>945</fpage>             <lpage>951</lpage>          </element-citation></ref><ref id="pcbi.1000002-Kidokoro1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kidokoro</surname><given-names>S</given-names></name><name name-style="western"><surname>Miki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Endo</surname><given-names>K</given-names></name><name name-style="western"><surname>Wada</surname><given-names>A</given-names></name><name name-style="western"><surname>Nagao</surname><given-names>H</given-names></name><etal/></person-group>             <year>1995</year>             <article-title>Remarkable activity enhancement of thermolysin mutants.</article-title>             <source>FEBS Lett</source>             <volume>367</volume>             <fpage>73</fpage>             <lpage>76</lpage>          </element-citation></ref><ref id="pcbi.1000002-Zhi1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhi</surname><given-names>W</given-names></name><name name-style="western"><surname>Srere</surname><given-names>PA</given-names></name><name name-style="western"><surname>Evans</surname><given-names>CT</given-names></name></person-group>             <year>1991</year>             <article-title>Conformational stability of pig citrate synthase and some active-site mutants.</article-title>             <source>Biochemistry</source>             <volume>30</volume>             <fpage>9281</fpage>             <lpage>9286</lpage>          </element-citation></ref><ref id="pcbi.1000002-Garcia1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>C</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>C</given-names></name><name name-style="western"><surname>Cavagnero</surname><given-names>S</given-names></name><name name-style="western"><surname>Dyson</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Wright</surname><given-names>PE</given-names></name></person-group>             <year>2000</year>             <article-title>Changes in the apomyoglobin folding pathway caused by mutation of the distal histidine residue.</article-title>             <source>Biochemistry</source>             <volume>39</volume>             <fpage>11227</fpage>             <lpage>11237</lpage>          </element-citation></ref><ref id="pcbi.1000002-Nagatani1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nagatani</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>A</given-names></name><name name-style="western"><surname>Shoichet</surname><given-names>BK</given-names></name><name name-style="western"><surname>Brinen</surname><given-names>LS</given-names></name><name name-style="western"><surname>Babbitt</surname><given-names>PC</given-names></name></person-group>             <year>2007</year>             <article-title>Stability for Function Trade-Offs in the Enolase Superfamily “Catalytic Module”.</article-title>             <source>Biochemistry</source>             <volume>46</volume>             <fpage>6688</fpage>             <lpage>6695</lpage>          </element-citation></ref><ref id="pcbi.1000002-DiNardo1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Di Nardo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Larson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>AR</given-names></name></person-group>             <year>2003</year>             <article-title>The relationship between conservation, thermodynamic stability, and function in the SH3 domain hydrophobic core.</article-title>             <source>J Mol Biol</source>             <volume>333</volume>             <fpage>641</fpage>             <lpage>655</lpage>          </element-citation></ref><ref id="pcbi.1000002-Quirk1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Quirk</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>C</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Raines</surname><given-names>RT</given-names></name></person-group>             <year>1998</year>             <article-title>His…Asp catalytic dyad of ribonuclease A: conformational stability of the wild-type, D121N, D121A, and H119A enzymes.</article-title>             <source>Biochemistry</source>             <volume>37</volume>             <fpage>17958</fpage>             <lpage>17964</lpage>          </element-citation></ref><ref id="pcbi.1000002-Schindler1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schindler</surname><given-names>T</given-names></name><name name-style="western"><surname>Perl</surname><given-names>D</given-names></name><name name-style="western"><surname>Graumann</surname><given-names>P</given-names></name><name name-style="western"><surname>Sieber</surname><given-names>V</given-names></name><name name-style="western"><surname>Marahiel</surname><given-names>MA</given-names></name><etal/></person-group>             <year>1998</year>             <article-title>Surface-exposed phenylalanines in the RNP1/RNP2 motif stabilize the cold-shock protein CspB from Bacillus subtilis.</article-title>             <source>Proteins</source>             <volume>30</volume>             <fpage>401</fpage>             <lpage>406</lpage>          </element-citation></ref><ref id="pcbi.1000002-Giver1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Giver</surname><given-names>L</given-names></name><name name-style="western"><surname>Gershenson</surname><given-names>A</given-names></name><name name-style="western"><surname>Freskgard</surname><given-names>PO</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>FH</given-names></name></person-group>             <year>1998</year>             <article-title>Directed evolution of a thermostable esterase.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>95</volume>             <fpage>12809</fpage>             <lpage>12813</lpage>          </element-citation></ref><ref id="pcbi.1000002-VandenBurg1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Van den Burg</surname><given-names>B</given-names></name><name name-style="western"><surname>Vriend</surname><given-names>G</given-names></name><name name-style="western"><surname>Veltman</surname><given-names>OR</given-names></name><name name-style="western"><surname>Venema</surname><given-names>G</given-names></name><name name-style="western"><surname>Eijsink</surname><given-names>VG</given-names></name></person-group>             <year>1998</year>             <article-title>Engineering an enzyme to resist boiling.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>95</volume>             <fpage>2056</fpage>             <lpage>2060</lpage>          </element-citation></ref><ref id="pcbi.1000002-Arnold1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>FH</given-names></name><name name-style="western"><surname>Giver</surname><given-names>L</given-names></name><name name-style="western"><surname>Gershenson</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>K</given-names></name></person-group>             <year>1999</year>             <article-title>Directed evolution of mesophilic enzymes into their thermophilic counterparts.</article-title>             <source>Ann N Y Acad Sci</source>             <volume>870</volume>             <fpage>400</fpage>             <lpage>403</lpage>          </element-citation></ref><ref id="pcbi.1000002-Serrano1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Serrano</surname><given-names>L</given-names></name><name name-style="western"><surname>Day</surname><given-names>AG</given-names></name><name name-style="western"><surname>Fersht</surname><given-names>AR</given-names></name></person-group>             <year>1993</year>             <article-title>Step-wise mutation of barnase to binase. A procedure for engineering increased stability of proteins and an experimental analysis of the evolution of protein stability.</article-title>             <source>J Mol Biol</source>             <volume>233</volume>             <fpage>305</fpage>             <lpage>312</lpage>          </element-citation></ref><ref id="pcbi.1000002-Takahashi1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Arai</surname><given-names>M</given-names></name><name name-style="western"><surname>Takenawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Sota</surname><given-names>H</given-names></name><name name-style="western"><surname>Xie</surname><given-names>QH</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Stabilization of hyperactive dihydrofolate reductase by cyanocysteine-mediated backbone cyclization.</article-title>             <source>J Biol Chem</source>             <volume>282</volume>             <fpage>9420</fpage>             <lpage>9429</lpage>          </element-citation></ref><ref id="pcbi.1000002-Wang1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Minasov</surname><given-names>G</given-names></name><name name-style="western"><surname>Shoichet</surname><given-names>BK</given-names></name></person-group>             <year>2002</year>             <article-title>Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.</article-title>             <source>J Mol Biol</source>             <volume>320</volume>             <fpage>85</fpage>             <lpage>95</lpage>          </element-citation></ref><ref id="pcbi.1000002-Chen1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shoichet</surname><given-names>B</given-names></name><name name-style="western"><surname>Bonnet</surname><given-names>R</given-names></name></person-group>             <year>2005</year>             <article-title>Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.</article-title>             <source>J Am Chem Soc</source>             <volume>127</volume>             <fpage>5423</fpage>             <lpage>5434</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bloom4"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bloom</surname><given-names>JD</given-names></name><name name-style="western"><surname>Labthavikul</surname><given-names>ST</given-names></name><name name-style="western"><surname>Otey</surname><given-names>CR</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>FH</given-names></name></person-group>             <year>2006</year>             <article-title>Protein stability promotes evolvability.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>103</volume>             <fpage>5869</fpage>             <lpage>5874</lpage>          </element-citation></ref><ref id="pcbi.1000002-GodoyRuiz1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Godoy-Ruiz</surname><given-names>R</given-names></name><name name-style="western"><surname>Perez-Jimenez</surname><given-names>R</given-names></name><name name-style="western"><surname>Ibarra-Molero</surname><given-names>B</given-names></name><name name-style="western"><surname>Sanchez-Ruiz</surname><given-names>JM</given-names></name></person-group>             <year>2004</year>             <article-title>Relation between protein stability, evolution and structure, as probed by carboxylic acid mutations.</article-title>             <source>J Mol Biol</source>             <volume>336</volume>             <fpage>313</fpage>             <lpage>318</lpage>          </element-citation></ref><ref id="pcbi.1000002-Zhao1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>FH</given-names></name></person-group>             <year>1999</year>             <article-title>Directed evolution converts subtilisin E into a functional equivalent of thermitase.</article-title>             <source>Protein Eng</source>             <volume>12</volume>             <fpage>47</fpage>             <lpage>53</lpage>          </element-citation></ref><ref id="pcbi.1000002-Matthews1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matthews</surname><given-names>BW</given-names></name></person-group>             <year>1993</year>             <article-title>Structural and genetic analysis of protein stability.</article-title>             <source>Annu Rev Biochem</source>             <volume>62</volume>             <fpage>139</fpage>             <lpage>160</lpage>          </element-citation></ref><ref id="pcbi.1000002-Guerois1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Guerois</surname><given-names>R</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>JE</given-names></name><name name-style="western"><surname>Serrano</surname><given-names>L</given-names></name></person-group>             <year>2002</year>             <article-title>Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.</article-title>             <source>J Mol Biol</source>             <volume>320</volume>             <fpage>369</fpage>             <lpage>387</lpage>          </element-citation></ref><ref id="pcbi.1000002-Schymkowitz1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schymkowitz</surname><given-names>J</given-names></name><name name-style="western"><surname>Borg</surname><given-names>J</given-names></name><name name-style="western"><surname>Stricher</surname><given-names>F</given-names></name><name name-style="western"><surname>Nys</surname><given-names>R</given-names></name><name name-style="western"><surname>Rousseau</surname><given-names>F</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>The FoldX web server: an online force field.</article-title>             <source>Nucleic Acids Res</source>             <volume>33</volume>             <fpage>W382</fpage>             <lpage>W388</lpage>          </element-citation></ref><ref id="pcbi.1000002-Tokuriki1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tokuriki</surname><given-names>N</given-names></name><name name-style="western"><surname>Stricher</surname><given-names>F</given-names></name><name name-style="western"><surname>Schymkowitz</surname><given-names>J</given-names></name><name name-style="western"><surname>Serrano</surname><given-names>L</given-names></name><name name-style="western"><surname>Tawfik</surname><given-names>DS</given-names></name></person-group>             <year>2007</year>             <article-title>The stability effects of protein mutations appear to be universally distributed.</article-title>             <source>J Mol Biol</source>             <volume>369</volume>             <fpage>1318</fpage>             <lpage>1332</lpage>          </element-citation></ref><ref id="pcbi.1000002-Sasidharan1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sasidharan</surname><given-names>R</given-names></name><name name-style="western"><surname>Chothia</surname><given-names>C</given-names></name></person-group>             <year>2007</year>             <article-title>The selection of acceptable protein mutations.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>104</volume>             <fpage>10080</fpage>             <lpage>10085</lpage>          </element-citation></ref><ref id="pcbi.1000002-Reichmann1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Reichmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>M</given-names></name><name name-style="western"><surname>Abramovich</surname><given-names>R</given-names></name><name name-style="western"><surname>Dym</surname><given-names>O</given-names></name><name name-style="western"><surname>Lim</surname><given-names>D</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Binding hot spots in the TEM1-BLIP interface in light of its modular architecture.</article-title>             <source>J Mol Biol</source>             <volume>365</volume>             <fpage>663</fpage>             <lpage>679</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bartlett1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bartlett</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Porter</surname><given-names>CT</given-names></name><name name-style="western"><surname>Borkakoti</surname><given-names>N</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>JM</given-names></name></person-group>             <year>2002</year>             <article-title>Analysis of catalytic residues in enzyme active sites.</article-title>             <source>J Mol Biol</source>             <volume>324</volume>             <fpage>105</fpage>             <lpage>121</lpage>          </element-citation></ref><ref id="pcbi.1000002-Wong1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>TS</given-names></name><name name-style="western"><surname>Roccatano</surname><given-names>D</given-names></name><name name-style="western"><surname>Zacharias</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwaneberg</surname><given-names>U</given-names></name></person-group>             <year>2006</year>             <article-title>A statistical analysis of random mutagenesis methods used for directed protein evolution.</article-title>             <source>J Mol Biol</source>             <volume>355</volume>             <fpage>858</fpage>             <lpage>871</lpage>          </element-citation></ref><ref id="pcbi.1000002-Zhang1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Baase</surname><given-names>WA</given-names></name><name name-style="western"><surname>Shoichet</surname><given-names>BK</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>KP</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>BW</given-names></name></person-group>             <year>1995</year>             <article-title>Enhancement of protein stability by the combination of point mutations in T4 lysozyme is additive.</article-title>             <source>Protein Eng</source>             <volume>8</volume>             <fpage>1017</fpage>             <lpage>1022</lpage>          </element-citation></ref><ref id="pcbi.1000002-Bershtein1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bershtein</surname><given-names>S</given-names></name><name name-style="western"><surname>Segal</surname><given-names>M</given-names></name><name name-style="western"><surname>Bekerman</surname><given-names>R</given-names></name><name name-style="western"><surname>Tokuriki</surname><given-names>N</given-names></name><name name-style="western"><surname>Tawfik</surname><given-names>DS</given-names></name></person-group>             <year>2006</year>             <article-title>Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein.</article-title>             <source>Nature</source>             <volume>444</volume>             <fpage>929</fpage>             <lpage>932</lpage>          </element-citation></ref><ref id="pcbi.1000002-Guo1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>HH</given-names></name><name name-style="western"><surname>Choe</surname><given-names>J</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>LA</given-names></name></person-group>             <year>2004</year>             <article-title>Protein tolerance to random amino acid change.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>101</volume>             <fpage>9205</fpage>             <lpage>9210</lpage>          </element-citation></ref><ref id="pcbi.1000002-Loh1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Loh</surname><given-names>E</given-names></name><name name-style="western"><surname>Choe</surname><given-names>J</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>LA</given-names></name></person-group>             <year>2007</year>             <article-title>Highly tolerated amino acid substitutions increase the fidelity of Escherichia coli DNA polymerase I.</article-title>             <source>J Biol Chem</source>             <volume>282</volume>             <fpage>12201</fpage>             <lpage>12209</lpage>          </element-citation></ref><ref id="pcbi.1000002-Sanchez1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sanchez</surname><given-names>IE</given-names></name><name name-style="western"><surname>Tejero</surname><given-names>J</given-names></name><name name-style="western"><surname>Gomez-Moreno</surname><given-names>C</given-names></name><name name-style="western"><surname>Medina</surname><given-names>M</given-names></name><name name-style="western"><surname>Serrano</surname><given-names>L</given-names></name></person-group>             <year>2006</year>             <article-title>Point mutations in protein globular domains: contributions from function, stability and misfolding.</article-title>             <source>J Mol Biol</source>             <volume>363</volume>             <fpage>422</fpage>             <lpage>432</lpage>          </element-citation></ref><ref id="pcbi.1000002-Goldman1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Goldman</surname><given-names>N</given-names></name><name name-style="western"><surname>Thorne</surname><given-names>JL</given-names></name><name name-style="western"><surname>Jones</surname><given-names>DT</given-names></name></person-group>             <year>1998</year>             <article-title>Assessing the impact of secondary structure and solvent accessibility on protein evolution.</article-title>             <source>Genetics</source>             <volume>149</volume>             <fpage>445</fpage>             <lpage>458</lpage>          </element-citation></ref><ref id="pcbi.1000002-Aharoni1"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Aharoni</surname><given-names>A</given-names></name><name name-style="western"><surname>Gaidukov</surname><given-names>L</given-names></name><name name-style="western"><surname>Khersonsky</surname><given-names>O</given-names></name><name name-style="western"><surname>Mc</surname><given-names>QGS</given-names></name><name name-style="western"><surname>Roodveldt</surname><given-names>C</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>The “evolvability” of promiscuous protein functions.</article-title>             <source>Nat Genet</source>             <volume>37</volume>             <fpage>73</fpage>             <lpage>76</lpage>          </element-citation></ref><ref id="pcbi.1000002-Roodveldt1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roodveldt</surname><given-names>C</given-names></name><name name-style="western"><surname>Tawfik</surname><given-names>DS</given-names></name></person-group>             <year>2005</year>             <article-title>Shared promiscuous activities and evolutionary features in various members of the amidohydrolase superfamily.</article-title>             <source>Biochemistry</source>             <volume>44</volume>             <fpage>12728</fpage>             <lpage>12736</lpage>          </element-citation></ref><ref id="pcbi.1000002-Tawfik1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tawfik</surname><given-names>DS</given-names></name></person-group>             <year>2006</year>             <article-title>Biochemistry. Loop grafting and the origins of enzyme species.</article-title>             <source>Science</source>             <volume>311</volume>             <fpage>475</fpage>             <lpage>476</lpage>          </element-citation></ref><ref id="pcbi.1000002-Oue1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Oue</surname><given-names>S</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Yano</surname><given-names>T</given-names></name><name name-style="western"><surname>Kagamiyama</surname><given-names>H</given-names></name></person-group>             <year>1999</year>             <article-title>Redesigning the substrate specificity of an enzyme by cumulative effects of the mutations of non-active site residues.</article-title>             <source>J Biol Chem</source>             <volume>274</volume>             <fpage>2344</fpage>             <lpage>2349</lpage>          </element-citation></ref><ref id="pcbi.1000002-Tomatis1"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tomatis</surname><given-names>PE</given-names></name><name name-style="western"><surname>Rasia</surname><given-names>RM</given-names></name><name name-style="western"><surname>Segovia</surname><given-names>L</given-names></name><name name-style="western"><surname>Vila</surname><given-names>AJ</given-names></name></person-group>             <year>2005</year>             <article-title>Mimicking natural evolution in metallo-beta-lactamases through second-shell ligand mutations.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>102</volume>             <fpage>13761</fpage>             <lpage>13766</lpage>          </element-citation></ref><ref id="pcbi.1000002-Morley1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Morley</surname><given-names>KL</given-names></name><name name-style="western"><surname>Kazlauskas</surname><given-names>RJ</given-names></name></person-group>             <year>2005</year>             <article-title>Improving enzyme properties: when are closer mutations better?</article-title>             <source>Trends Biotechnol</source>             <volume>23</volume>             <fpage>231</fpage>             <lpage>237</lpage>          </element-citation></ref><ref id="pcbi.1000002-Gerlt1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gerlt</surname><given-names>JA</given-names></name><name name-style="western"><surname>Babbitt</surname><given-names>PC</given-names></name></person-group>             <year>2001</year>             <article-title>Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies.</article-title>             <source>Annu Rev Biochem</source>             <volume>70</volume>             <fpage>209</fpage>             <lpage>246</lpage>          </element-citation></ref><ref id="pcbi.1000002-Besenmatter1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Besenmatter</surname><given-names>W</given-names></name><name name-style="western"><surname>Kast</surname><given-names>P</given-names></name><name name-style="western"><surname>Hilvert</surname><given-names>D</given-names></name></person-group>             <year>2007</year>             <article-title>Relative tolerance of mesostable and thermostable protein homologs to extensive mutation.</article-title>             <source>Proteins</source>             <volume>66</volume>             <fpage>500</fpage>             <lpage>506</lpage>          </element-citation></ref></ref-list></back></article>